Caricamento...
Loteprednol Etabonate (Submicron) Ophthalmic Gel 0.38%: A Review in Post-Operative Inflammation and Pain Following Ocular Surgery
Loteprednol etabonate ophthalmic gel 0.38% (Lotemax(®) SM; hereafter referred to as loteprednol etabonate gel 0.38%) is a topical ophthalmic corticosteroid approved in the USA for the treatment of post-operative inflammation and pain following ocular surgery. This formulation provides improved drug...
Salvato in:
| Pubblicato in: | Clin Drug Investig |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer International Publishing
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7736007/ https://ncbi.nlm.nih.gov/pubmed/32172521 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-020-00899-2 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|